13.74USD+0.07%Mkt Cap: 3.61B $P/E: 17.60Today
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, …
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap3.61B $
Enterprise Value11.03B $
Revenue (TTM)6.13B $
Gross Profit3.31B $
Net Income (TTM)187.00M $
Revenue/Share23.49 USD
Last Price13.74 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)17.60
P/E (Forward)3.78
PEG—
EV/EBITDA7.05
EV/Revenue1.80
P/S0.59
P/B3.59
EPS (TTM)0.78
EPS (Forward)3.64
52W Range
5.690100% of range13.74
52W High13.74 USD
52W Low5.690 USD
Profitability
Gross Margin53.30%
Oper. Margin20.73%
EBITDA Margin25.53%
Profit Margin3.01%
ROE24.87%
ROA1.45%
Growth
Revenue Growth-2.30%
Earnings Growth-28.30%
Cash Flow & Leverage
Operating CF700.00M $
CapEx (TTM)316.00M $
FCF Margin8.01%
FCF Yield13.61%
Net Debt7.42B $
Net Debt/EBITDA4.74
Balance Sheet
Debt/Equity11.49
Current Ratio1.95
Quick Ratio1.00
Book Value/Sh3.831 USD
Cash/Share4.311 USD
Dividends
Fwd Div Rate0.0800 USD
Trail. Div Rate0.0800 USD
Div. Yield0.58%
5Y Avg Yield—
Payout Ratio10.26%
Ex-Div DateAug 14, 2026
Pay DateSep 10, 2026
Analyst Consensus
Rating—
Target (Mean)11.25 USD
Upside (mean)-18.1%
Target Range8.000 USD – 14.00 USD
$8.000-18.1% to mean$14.00
# Analysts4
Ownership
Shares Out.262.61M
Float242.99M
Insiders0.46%
Institutions84.05%
Short Interest
Short Ratio6.5d
Short % Float7.28%
Short % Out.6.40%
Shares Short16.81M
Short (prev mo.)17.09M
Technical
SMA 5013.54 (+1.5%)
SMA 2009.921 (+38.5%)
Beta1.52
S&P 52W Chg18.16%
Avg Vol (30d)2.07M
Avg Vol (10d)2.91M
Technical Indicators
RSI (14)74.8
MACD0.0683
MACD Signal0.0601
MACD Hist.+0.0082
BB Upper13.74 USD
BB Middle13.60 USD
BB Lower13.45 USD
BB Width2.15%
ATR (14)0.0438 USD
Vol Ratio (20d)1.42x